Current Oncology

Established in 1994, Current Oncology is a peer-reviewed, Canadian based and Internationally respected journal. Published bi-monthly plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Current Oncology is published by Multimed Inc.

Current Oncology is indexed/covered in MEDLINE, PubMed, Embase, Scopus, Crossref, Index Copernicus, DOAJ (Directory of Open Access Journals), Google Scholar, EMCare, Research Databases, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition. Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC), the U.S. National Library of Medicine's digital archive of biomedical and life sciences journal literature. It is also available in the databases of 100 libraries worldwide, and is a participant of the HINARI program.

The information provided on the Current Oncology website is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.



Journal Announcement: Soft-tissue Sarcoma Supplement Now Online

Soft-tissue sarcomas have been, until recently, a neglected topic of investigation and publication. This is explained, in comparison with epithelial cancers, by a slower understanding of their pathogenesis and a lack of effective systemic therapies. The past few years, however, have seen changes in their classification, as well as improvements in their treatment, from surgery and radiotherapy to systemic therapy. Our Guest Editor, Dr. Thierry Alcindor (Associate Professor of Oncology & Medicine at McGill University) revisits soft-tissue sarcomas in this special journal issue.  
Posted: 2020-02-13



Current Oncology is pleased to announce that effective June 1, 2019 Dr. Habeeb Majeed will take on the role of Managing Editor and Dr. Sharlene Gill will assume the role of Deputy Editor.


After many years, our previous Managing Editor, Dr. Martin Chasen, has decided to step down and pursue other academic and clinical interests.  Dr. Chasen was instrumental in helping shape and build Current Oncology into a national journal of international reputation.  He helped steer its success in achieving a significant impact factor and its inclusion in both Pubmed and Medline.


We wish Dr. Chasen much success in his future ventures!


As we move forward, we have built a strong team with both Dr. Majeed and Dr. Gill at the helm.

Our future plans include, amongst others, building new relationships with key oncology organizations across Canada, and highlighting their influential work to our readers both in Canada and internationally.  Along with Dr. Majeed and Dr. Gill we aim to achieve these goals and strengthen the influence of Current Oncology to our over 350,000 viewers worldwide.


We have already ensured a smooth transition for all our stakeholders and we look forward to continuing to advance Current Oncology into the foreseeable future.

Posted: 2019-06-10

Journal Announcement: Canadian Costing Series Now Published!

The Canadian Centre for Applied Research in Cancer Control (ARCC), in partnership with the Ontario Institute for Cancer Research (OICR) have partnered with us to publish a special series on Canadian-specific costing research that involves the use of administrative data.  Click here to view the series!  
Posted: 2019-04-29
More Announcements...

Vol 26 (2019): A fresh look at Therapeutic Advances in Soft-tissue Sarcoma

Table of Contents


Original Article(s)

Bone and Soft Tissue Oncology

K. M. Ingley, S. Cohen-Gogo, A. A. Gupta

Medical Oncology

O. Ayodele, A. R. Abdul Razak

Review Article(s)